Skip to main content
森萱医药 logo

森萱医药 — Investor Relations & Filings

Ticker · 920946 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2025-08-28 Governance Information
Country CN China
Listing Beijing Stock Exchange 920946

About 森萱医药

https://www.senxuan.cn/

Jiangsu Senxuan Pharmaceutical Co., Ltd. specializes in the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and specialized fine chemicals. The company’s product portfolio includes key intermediates for antiviral medications, such as those used in the treatment of HIV, and anticonvulsant agents like Primidone. Additionally, it produces high-purity chemical solvents including 1,4-dioxane and 1,3-dioxolane for diverse industrial applications. Senxuan Pharmaceutical maintains a focus on advanced chemical synthesis and large-scale manufacturing capabilities, adhering to international quality standards to support the global life sciences and chemical sectors. Its operations are characterized by a commitment to technical innovation and the supply of critical chemical building blocks for complex therapeutic formulations.

Recent filings

Filing Released Lang Actions
董事会审计委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the "Work Rules of the Board Audit Committee" of Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the structure, responsibilities, procedures, and disclosure requirements of the audit committee under the board of directors. It is a governance-related document focusing on internal rules and oversight mechanisms rather than financial results, audit opinions, or announcements of voting results. It does not contain financial statements or audit reports but rather the internal governance framework for the audit committee. Therefore, it fits best under Governance Information (CGR). The document length is sufficient and it is not a brief announcement or certification, so it is not RPA or RNS. Hence, the classification is CGR with high confidence.
2025-08-28 Chinese
募集资金管理制度
Regulatory Filings Classification · 95% confidence The document is a detailed internal management system regarding the management of raised funds (募集资金管理制度) by 江苏森萱医药股份有限公司. It includes sections on the storage, usage, supervision, and responsibility related to the raised funds. The document references board meetings and shareholder meetings for approval but does not contain financial statements or financial results. It is a regulatory announcement about the company's internal policies and procedures for managing capital raised from investors, rather than a financial report or earnings release. It is not a report publication announcement since it contains substantive content rather than just announcing a report. It is not a certification or attestation document. The content fits best under Regulatory Filings (RNS) as it is a compliance-related announcement about fundraising management rules and internal controls, which do not fit other more specific categories.
2025-08-28 Chinese
董事、高级管理人员内部问责制度
Governance Information Classification · 95% confidence The document is a detailed internal accountability system for directors and senior management of Jiangsu Senxuan Pharmaceutical Co., Ltd. It includes the scope, principles, responsibilities, procedures, and penalties related to internal accountability. It is a governance-related document focusing on internal rules and management practices rather than financial data, earnings, or regulatory filings. There is no indication of financial statements, audit results, or shareholder voting results. The document is not a report publication announcement or a certification. Therefore, it fits best under Governance Information (CGR). The document length is 3426 characters, which is relatively short but contains substantive governance content, not just an announcement or notice.
2025-08-28 Chinese
高级管理人员年薪考核细则
Board/Management Information Classification · 95% confidence The document is a detailed announcement from Jiangsu Senxuan Pharmaceutical Co., Ltd. regarding the company's internal management system specifically about the senior management personnel annual salary assessment rules. It includes detailed provisions on salary structure, performance evaluation, and disciplinary measures. The document mentions the board meeting where the rules were approved but does not indicate it is a full annual report, audit report, or financial statement. It is not a call transcript, earnings release, or capital update. It is a governance-related document focusing on internal management and compensation policies for senior management. Therefore, it fits best under Board/Management Information (MANG) as it relates to senior management policies and board resolutions affecting management compensation.
2025-08-28 Chinese
内幕信息知情人报备制度
Regulatory Filings Classification · 95% confidence The document is a detailed internal policy and procedural announcement regarding the insider information reporting system of Jiangsu Senxuan Pharmaceutical Co., Ltd. It includes the scope of insider information, the responsibilities of insiders, confidentiality rules, and the process for reporting insider information to the Beijing Stock Exchange. It also contains a voting result from the board meeting approving the policy. There are no financial statements, earnings data, or investor presentation content. The document is regulatory in nature, focusing on compliance and internal governance related to insider information. It is not an annual report, earnings release, or any financial report. It is not a simple announcement of a report publication but a substantive regulatory compliance document. Therefore, the best fitting category is Regulatory Filings (RNS). The document length is about 4800 characters, which is substantive enough to be a full regulatory filing rather than a brief announcement.
2025-08-28 Chinese
内部重要信息报告制度
Governance Information Classification · 95% confidence The document is titled as an internal important information reporting system of Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the company's internal procedures and responsibilities for reporting material information that could affect stock prices. It includes sections on the scope of information, reporting procedures, management responsibilities, and legal compliance. The document is a policy or governance document related to internal information reporting and disclosure obligations. It is not a financial report, earnings release, or announcement of voting results. It is not a regulatory filing of a specific event but rather a governance framework document. Therefore, it fits best under Governance Information (CGR). The document length is 6732 characters, which is substantial and contains detailed governance content, not a brief announcement or certification. Hence, the classification is CGR with high confidence.
2025-08-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.